Casebia Therapeutics
Business Services · 51-200 Employees
View Company Info for Free
Overview
Phone Number
(857) 270-5100Website
www.casebia.comRevenue
$16.1 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Casebia Therapeutics
Casebia Therapeutics is a novel joint venture between Bayer and CRISPR Therapeutics, formed in 2016 to advance CRISPR/Cas9 gene-editing therapeutics to discover and develop curative treatments for patients suffering from genetic diseases of the eye, ear and blood, as well as autoimmune, metabolic and cardiovascular conditions. The Casebia technology platform is moving genetic medicine forward by enabling new genetic engineering tools and revolutionary delivery methods for gene editing that target treatments precisely to specific areas of the body affected by disease.Explore more
Casebia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Casebia Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Casebia Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Casebia Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Casebia Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Casebia Therapeutics
Funding: Get notified immidiatlly once Casebia Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Casebia Therapeutics recently announced quarterly report
Click to see if Casebia Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Casebia Therapeutics launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Casebia Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Casebia Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Casebia Therapeutics.
Casebia Therapeutics Tech Stack
A closer look at the technologies used by Casebia Therapeutics
Casebia Therapeutics News & Media
Casebia Announces Appointment of New SVP, Head of Technical Operations
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casebia Announces Appointment of Stephen Kennedy as SVP, Head of Technical OperationsCasebia Advances Genetic Engineering with New Tools and Techniques
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Casebia and its collaborators will be presenting 6 posters and 4 oral presentations – from 10 accepted abstracts – during the ASGCT annual conferenceCasebia Therapeutics Expands Leadership Team with Addition of Dr. Adel Nada as Chief Medical Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--#CRISPR--Casebia, a gene editing company discovering and developing curative treatments for genetic diseases, named Dr. Adel Nada as Chief Medical Officer
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Casebia Therapeutics
Sign Up For FreeTo access detailed company insights
Casebia Therapeutics is a novel joint venture between Bayer and CRISPR Therapeutics, formed in 2016 to advance CRISPR/Cas9 gene-editing therapeutics to discover and develop curative treatments for patients suffering from genetic diseases of the eye, ear and blood, as well as autoimmune, metabolic and cardiovascular conditions. The Casebia technolog... Read More
